Correction
Correction: Durable Therapeutic Efficacy
Utilizing Combinatorial Blockade against IDO,
CTLA-4, and PD-L1 in Mice with Brain Tumors
Clinical
Cancer
Research
In this article (Clin Cancer Res 2014;20:5290–301), which was published in the
October 15, 2014, issue of Clinical Cancer Research (1), the phrase ". . .whereas twotailed unpaired Student t tests were used for paired groups," within a sentence in the
statistical analysis section, generated confusion among readers. The authors have
provided clarification, and the new paragraph should read as follows:
Data were analyzed using Prism 4.0 software (GraphPad Software). Experiments were
repeated at least two times each. Data are represented as the mean SEM for all figure
panels in which error bars are shown. The P values represent ANOVA for groups of
3 or more, whereas two-tailed unpaired Student t tests were used for comparisons
between two groups. A P value of less than 0.05 was considered statistically
significant.
The authors regret this error.
Reference
1. Wainwright DA, Chang AL, Dey M, Balyasnikova IV, Kim CK, Tobias A, et al. Durable therapeutic
efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain
tumors. Clin Cancer Res 2014;20:5290–301.
Published online February 2, 2015.
doi: 10.1158/1078-0432.CCR-14-3211
Ó2015 American Association for Cancer Research.
662 Clin Cancer Res; 21(3) February 1, 2015
Downloaded from clincancerres.aacrjournals.org on June 17, 2017. © 2015 American Association for Cancer Research.
Correction: Durable Therapeutic Efficacy Utilizing Combinatorial
Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain
Tumors
Clin Cancer Res 2015;21:662.
Updated version
Cited articles
E-mail alerts
Reprints and
Subscriptions
Permissions
Access the most recent version of this article at:
http://clincancerres.aacrjournals.org/content/21/3/662
This article cites 1 articles, 1 of which you can access for free at:
http://clincancerres.aacrjournals.org/content/21/3/662.full.html#ref-list-1
Sign up to receive free email-alerts related to this article or journal.
To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at
[email protected].
To request permission to re-use all or part of this article, contact the AACR Publications Department at
[email protected].
Downloaded from clincancerres.aacrjournals.org on June 17, 2017. © 2015 American Association for Cancer Research.